The Director of the SFO has opened a criminal investigation into the commercial practices of GlaxoSmithKline (GSK) and its subsidiaries following allegations of corruption in China.
GSK is also investigating claims that staff have been involved in bribery in Poland, Iraq, Jordan and Lebanon. GSK, the largest British pharmaceuticals company, was involved in a corruption scandal last year when Chinese officials accused it of operating a bribery network in the country to bribe doctors to use its…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
